Back to Screener

Avantor, Inc. (AVTR)

Price$8.50

Favorite Metrics

Price vs S&P 500 (26W)-45.21%
Price vs S&P 500 (4W)3.85%
Market Capitalization$5.75B

All Metrics

P/CF (Annual)9.21x
Book Value / Share (Quarterly)$8.16
P/TBV (Annual)3.30x
Revenue Growth (3Y)-4.46%
Cash Flow / Share (Quarterly)$0.73
Price vs S&P 500 (YTD)-29.76%
Gross Margin (TTM)32.65%
Net Profit Margin (TTM)-8.09%
EPS (TTM)$-0.78
10-Day Avg Trading Volume8.94M
EPS Excl Extra (TTM)$-0.78
Revenue Growth (5Y)0.49%
EPS (Annual)$-0.78
Dividend / Share (Annual)$0.00
ROI (Annual)-5.57%
Gross Margin (Annual)32.65%
Net Profit Margin (5Y Avg)4.78%
Cash / Share (Quarterly)$0.54
Revenue Growth QoQ (YoY)-1.36%
ROA (Last FY)-4.50%
Revenue Growth TTM (YoY)-3.41%
EBITD / Share (TTM)$0.21
ROE (5Y Avg)7.26%
Operating Margin (TTM)-3.83%
Cash Flow / Share (Annual)$0.73
P/B Ratio1.03x
P/B Ratio (Quarterly)1.40x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.42x
Net Interest Coverage (TTM)-1.49x
ROA (TTM)-4.37%
EPS Growth QoQ (YoY)-89.48%
EV / EBITDA (TTM)63.71x
EPS Incl Extra (Annual)$-0.78
Current Ratio (Annual)1.78x
Quick Ratio (Quarterly)1.18x
3-Month Avg Trading Volume11.07M
52-Week Price Return-43.71%
EV / Free Cash Flow (Annual)18.84x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.48
P/S Ratio (Annual)0.88x
Asset Turnover (Annual)0.56x
52-Week High$16.17
Operating Margin (5Y Avg)9.95%
EPS Excl Extra (Annual)$-0.78
CapEx CAGR (5Y)15.90%
26-Week Price Return-38.32%
Quick Ratio (Annual)1.18x
13-Week Price Return-29.28%
Total Debt / Equity (Annual)0.71x
Current Ratio (Quarterly)1.78x
Enterprise Value$9,327.799
Revenue / Share Growth (5Y)-2.56%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)12.09%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)5.70x
Pretax Margin (Annual)-6.74%
Cash / Share (Annual)$0.54
3-Month Return Std Dev43.43%
Gross Margin (5Y Avg)33.74%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)3.76%
ROE (Last FY)-9.53%
Net Interest Coverage (Annual)-1.49x
EPS Basic Excl Extra (Annual)$-0.78
P/FCF (TTM)11.61x
Receivables Turnover (TTM)6.21x
EV / Free Cash Flow (TTM)18.84x
Total Debt / Equity (Quarterly)0.71x
EPS Incl Extra (TTM)$-0.78
Receivables Turnover (Annual)6.21x
ROI (TTM)-5.35%
P/S Ratio (TTM)0.88x
Pretax Margin (5Y Avg)6.65%
Revenue / Share (Annual)$9.63
Tangible BV / Share (Annual)$3.48
Forward P/E10.82x
Free OCF CAGR (5Y)-10.63%
Price vs S&P 500 (52W)-78.34%
Year-to-Date Return-25.83%
5-Day Price Return3.66%
EPS Normalized (Annual)$-0.78
ROA (5Y Avg)2.61%
Net Profit Margin (Annual)-8.09%
Month-to-Date Return8.42%
Cash Flow / Share (TTM)$1.13
EBITD / Share (Annual)$-0.38
Operating Margin (Annual)-3.83%
LT Debt / Equity (Annual)0.70x
P/CF (TTM)9.21x
ROI (5Y Avg)3.16%
LT Debt / Equity (Quarterly)0.70x
EPS Basic Excl Extra (TTM)$-0.78
P/TBV (Quarterly)3.30x
P/B Ratio (Annual)1.40x
Inventory Turnover (TTM)5.70x
Pretax Margin (TTM)-6.74%
Book Value / Share (Annual)$8.16
Price vs S&P 500 (13W)-31.67%
Beta0.99x
P/FCF (Annual)11.61x
Revenue / Share (TTM)$9.66
ROE (TTM)-9.02%
52-Week Low$7.26

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.35
3.31
3.31
2.80

Industry Peers — Lab Analytical Instruments(22)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
AVTRAvantor, Inc.
0.88x0.49%32.65%-3.83%$8.50
AAgilent Technologies Inc.
4.83x5.41%52.60%20.40%$120.96
WATWaters Corp
10.18x6.00%59.28%25.36%$335.61
MTDMettler-Toledo International
6.66x5.47%59.37%26.05%$1324.66
ILMNIllumina Inc
4.69x6.04%66.61%18.44%$132.86
RVTYRevvity, Inc.
3.64x-5.46%54.77%12.49%$93.03
BIOBio-Rad Laboratories, Inc.Class A
3.17x0.29%52.01%1.59%$303.34
BIO.BBio-Rad Laboratories, Inc. Class B
3.17x0.29%52.01%1.59%$277.00
BRKRBruker Corporation
1.81x11.57%47.13%1.40%$41.10
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
1.81x11.57%47.13%1.40%$320.13
TXG10x Genomics, Inc. Class A Common Stock
5.18x16.56%69.13%-9.49%$24.59

About

Avantor supplies essential laboratory products, equipment, and services to life sciences, healthcare, and advanced materials industries globally. The company operates two segments—Laboratory Solutions and Bioscience Production—offering high-purity chemicals, reagents, lab consumables, chromatography products, and specialized procurement services. Its portfolio serves biopharma, healthcare, government, and advanced technology customers across the Americas, Europe, and AMEA.